For patients with cardiac arrest and a shockable rhythm, automated external defibrillators (AEDs) in private homes improve outcomes but cannot be considered cost-effective at current pricing, according to a study published online Oct. 25 in JAMA Internal Medicine to coincide with the European Resuscitation Council Congress, held from Oct. 23 to 25 in Rotterdam, Netherlands.
Getting Started is Easy and Yes It's FREE
What is The Ecosystem?
The Token Revolution.
The Next Bitcoin Moment.
